Annex Healthcare, a clinical stage pharmaceutical company based in New York City, focuses on developing medicinal cannabinoid and psychedelic products for various health conditions. It has 28 R&D programs and six clinical trials underway.
annex Healthcare (IXHL) reported a negative EPS surprise in its most recent quarterly earnings. For the most recent quarter, annex Healthcare's actual EPS was -$7.97, missing the estimate of -$0.74 per share, resulting in a -978.53% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.